Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Novartis : to close Swiss plant, 50 jobs to go

06/09/2021 | 08:41am EDT
Switzerland's national flag flies in front of the logo of Swiss drugmaker Novartis in Basel

ZURICH (Reuters) - Novartis plans to close a plant in the southern Swiss town of Locarno, the drugmaker said on Wednesday, citing falling demand for testing products.

Around 50 jobs are set to go by shuttering the facility in stages by the end of 2023, it added in a statement.

The Pharmanalytica testing facility in Locarno specialises in performing stability tests and specific release tests for Novartis products.

(Reporting by Michael Shields, editing by Louise Heavens)


ę Reuters 2021
All news about NOVARTIS AG
07:08aEU Approves Two More Manufacturing Sites for Pfizer-BioNTech Covid Vaccine
DJ
04:35aNOVARTISá : Kesimpta« (ofatumumab) data show long-term preservation of IgG/IgM l..
PU
06/20NOVARTISá : Gene Therapy Zolgensma Shows Efficacy in Children With Spinal Muscul..
MT
06/18NOVARTISá : Study Shows Improved Motor Function in Children with Spinal Muscular..
MT
06/18PRESS RELEASEá : Novartis: New Zolgensma data -3-
DJ
06/18PRESS RELEASEá : Novartis: New Zolgensma data -2-
DJ
06/18PRESS RELEASEá : Novartis: New Zolgensma data demonstrate age-appropriate develo..
DJ
06/18NOVARTISá : New Zolgensma data demonstrate age-appropriate development when used..
DJ
06/18CureVac Could Allow Manufacturing Partners To Produce Rival Vaccines
MT
06/17NOVARTIS INDIAá : Consolidated Net Profit Climbs in Fiscal Q4
MT
More news
Financials (USD)
Sales 2021 51 668 M - -
Net income 2021 9 938 M - -
Net Debt 2021 22 978 M - -
P/E ratio 2021 20,9x
Yield 2021 3,50%
Capitalization 211 B 210 B -
EV / Sales 2021 4,52x
EV / Sales 2022 4,23x
Nbr of Employees 110 000
Free-Float 87,4%
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 93,78 $
Average target price 106,77 $
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
NameTitle
Vasant Narasimhan Chief Executive Officer
Harry Werner Kirsch Chief Financial Officer
Hans J÷rg Reinhardt Independent Non-Executive Chairman
John Tsai Chief Medical Officer
Klaus Moosmayer Chief Ethics Risk & Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG3.00%210 615
JOHNSON & JOHNSON4.10%431 456
ROCHE HOLDING AG12.99%328 650
PFIZER, INC.7.09%220 661
ABBVIE INC.7.07%202 639
ELI LILLY AND COMPANY29.44%202 413